Medacta Group SA
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Medacta Group SA (MEDGF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.172x
Based on the latest financial reports, Medacta Group SA (MEDGF) has a cash flow conversion efficiency ratio of 0.172x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($72.95 Million) by net assets ($424.61 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medacta Group SA - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Medacta Group SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Medacta Group SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medacta Group SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
South Plains Financial Inc
NASDAQ:SPFI
|
0.049x |
|
Anhui Estone Materials Technology Co Ltd
SHG:688733
|
-0.014x |
|
SLC Agrícola S.A
SA:SLCE3
|
0.152x |
|
MULLEN AUT. INC. DL -001
F:1N5
|
N/A |
|
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094
|
0.005x |
|
Shanghai Jiao Yun Group Co Ltd
SHG:600676
|
0.026x |
|
Empresa Nacional de Telecomunicaciones SA
SN:ENTEL
|
0.090x |
|
Eco World Develop Group
KLSE:8206
|
0.031x |
Annual Cash Flow Conversion Efficiency for Medacta Group SA (2016–2024)
The table below shows the annual cash flow conversion efficiency of Medacta Group SA from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $379.66 Million | $107.14 Million | 0.282x | +23.97% |
| 2023-12-31 | $330.04 Million | $75.13 Million | 0.228x | -14.95% |
| 2022-12-31 | $274.65 Million | $73.51 Million | 0.268x | +12.08% |
| 2021-12-31 | $226.40 Million | $54.06 Million | 0.239x | -34.00% |
| 2020-12-31 | $164.72 Million | $59.59 Million | 0.362x | +4.57% |
| 2019-12-31 | $123.23 Million | $42.63 Million | 0.346x | -53.60% |
| 2018-12-31 | $89.07 Million | $66.41 Million | 0.746x | +46.94% |
| 2017-12-31 | $101.67 Million | $51.59 Million | 0.507x | +32.33% |
| 2016-12-31 | $146.87 Million | $56.31 Million | 0.383x | -- |